[Comparative clinical study of DL-8280 and cefaclor for suppurative skin and soft tissue infections by a double-blind method]. 1984

K Fujita, and M Nakano, and E Nonami, and T Shishiba, and M Katsumata, and N Horie, and R Watanabe, and A Kukita, and S Watanabe, and T Someya

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010078 Oxazines Six-membered heterocycles containing an oxygen and a nitrogen.
D002433 Cefaclor Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R-(6alpha,7beta(R*)))-,Ceclor,Cefaclor Anhydrous,Cefaclor Monohydrate,Keclor,Lilly 99638,S-6472,S 6472,S6472
D002506 Cephalexin A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,Cefalexin,Cephalexin Dihydride,Cephalexin Hemihydrate,Cephalexin Hydrochloride,Cephalexin Monohydrate,Cephalexin Monohydrochloride,Cephalexin Monohydrochloride, Monohydrate,Cephalexin, (6R-(6alpha,7alpha(R*)))-Isomer,Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer,Cephalexin, (6R-(6alpha,7beta))-Isomer,Cephalexin, Monosodium Salt,Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer,Ceporexine,Palitrex
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K Fujita, and M Nakano, and E Nonami, and T Shishiba, and M Katsumata, and N Horie, and R Watanabe, and A Kukita, and S Watanabe, and T Someya
March 1989, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
K Fujita, and M Nakano, and E Nonami, and T Shishiba, and M Katsumata, and N Horie, and R Watanabe, and A Kukita, and S Watanabe, and T Someya
September 1984, Hinyokika kiyo. Acta urologica Japonica,
K Fujita, and M Nakano, and E Nonami, and T Shishiba, and M Katsumata, and N Horie, and R Watanabe, and A Kukita, and S Watanabe, and T Someya
September 1986, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
K Fujita, and M Nakano, and E Nonami, and T Shishiba, and M Katsumata, and N Horie, and R Watanabe, and A Kukita, and S Watanabe, and T Someya
December 1988, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
K Fujita, and M Nakano, and E Nonami, and T Shishiba, and M Katsumata, and N Horie, and R Watanabe, and A Kukita, and S Watanabe, and T Someya
November 1988, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
K Fujita, and M Nakano, and E Nonami, and T Shishiba, and M Katsumata, and N Horie, and R Watanabe, and A Kukita, and S Watanabe, and T Someya
October 1985, The Japanese journal of antibiotics,
K Fujita, and M Nakano, and E Nonami, and T Shishiba, and M Katsumata, and N Horie, and R Watanabe, and A Kukita, and S Watanabe, and T Someya
October 1984, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
K Fujita, and M Nakano, and E Nonami, and T Shishiba, and M Katsumata, and N Horie, and R Watanabe, and A Kukita, and S Watanabe, and T Someya
October 1988, The Japanese journal of antibiotics,
K Fujita, and M Nakano, and E Nonami, and T Shishiba, and M Katsumata, and N Horie, and R Watanabe, and A Kukita, and S Watanabe, and T Someya
September 1984, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
K Fujita, and M Nakano, and E Nonami, and T Shishiba, and M Katsumata, and N Horie, and R Watanabe, and A Kukita, and S Watanabe, and T Someya
December 1983, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!